Alnylam Therapies
Select below to explore a breadth of educational, scientific, and clinical resources related to the FDA-approved uses of our therapies.
Our Therapies
AMVUTTRA® (vutrisiran)
Explore clinical and educational resources related to the use of vutrisiran in adult patients with the polyneuropathy of hereditary ATTR (hATTR, also known as ATTRv) amyloidosis or with the cardiomyopathy of wild-type or hereditary ATTR amyloidosis
GIVLAARI® (givosiran)
Explore clinical and educational resources related to the use of givosiran in adult patients with acute hepatic porphyria (AHP)
ONPATTRO® (patisiran)
Explore clinical and educational resources related to the use of patisiran in adult patients with the polyneuropathy of hereditary ATTR (hATTR, also known as ATTRv) amyloidosis
OXLUMO® (lumasiran)
Explore clinical and educational resources related to the use of lumasiran in pediatric and adult patients with primary hyperoxaluria type 1 (PH1)
